PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot… - Molecular cancer, 2023 - Springer
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
F Peng, M Liao, R Qin, S Zhu, C Peng, L Fu… - Signal transduction and …, 2022 - nature.com
Regulated cell death (RCD), also well-known as programmed cell death (PCD), refers to the
form of cell death that can be regulated by a variety of biomacromolecules, which is …
form of cell death that can be regulated by a variety of biomacromolecules, which is …
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
The intricate molecular pathways governing cancer development and progression have
spurred intensive investigations into novel therapeutic targets. Glycogen Synthase Kinase-3 …
spurred intensive investigations into novel therapeutic targets. Glycogen Synthase Kinase-3 …
[HTML][HTML] CCL5/CCR5 axis in human diseases and related treatments
Z Zeng, T Lan, Y Wei, X Wei - Genes & diseases, 2022 - Elsevier
To defense harmful stimuli or maintain the immune homeostasis, the body produces and
recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among …
recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among …
Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
M Akbarzadeh, A Mihanfar, S Akbarzadeh, B Yousefi… - Life Sciences, 2021 - Elsevier
Abstract Phosphoinositide-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling pathway is one of the most important proliferative signaling pathways with critical …
signaling pathway is one of the most important proliferative signaling pathways with critical …
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
V Koh, J Chakrabarti, M Torvund, N Steele, JA Hawkins… - Cancer letters, 2021 - Elsevier
Tumors evade immune surveillance by expressing Programmed Death-Ligand 1 (PD-L1),
subsequently inhibiting CD8+ cytotoxic T lymphocyte function. Response of gastric cancer to …
subsequently inhibiting CD8+ cytotoxic T lymphocyte function. Response of gastric cancer to …
Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies
The failure of chemotherapy is a major challenge nowadays, and in order to ensure effective
treatment of cancer patients, it is of great importance to reveal the molecular pathways and …
treatment of cancer patients, it is of great importance to reveal the molecular pathways and …
Rutin (Bioflavonoid) as cell signaling pathway modulator: Prospects in treatment and chemoprevention
Cancer is a complex ailment orchestrated by numerous intrinsic and extrinsic pathways.
Recent research has displayed a deep interest in developing plant-based cancer …
Recent research has displayed a deep interest in developing plant-based cancer …
Chemotherapy resistance: Role of mitochondrial and autophagic components
E Bahar, SY Han, JY Kim, H Yoon - Cancers, 2022 - mdpi.com
Simple Summary Chemotherapy resistance is a common occurrence during cancer
treatment that cancer researchers are attempting to understand and overcome. Mitochondria …
treatment that cancer researchers are attempting to understand and overcome. Mitochondria …